NEW YORK, Feb. 13 - Beckman Coulter and Specialty Laboratories have signed a cross-licensing agreement to develop multi-analyte assays for the Beckman Progressive microarray platform, the instrument manufacturer said on Wednesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.